Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the correlation between change of HbA1c, urinary
glucose excretion and other factors when ipragliflozin is added to preexisting therapy in
subjects with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Asan Medical Center
Collaborators:
Astellas Pharma Korea, Inc. Kyung Hee University Hospital at Gangdong Samsung Medical Center Severance Hospital